US EditionFDA Commissioner Says TrumpRx Is a "Major Step" Toward Making Prescription Medications Affordable
TrumpRx offers American patients discounts averaging 50% to 85% on Pfizer drugs and aims to align US drug prices with those in other developed nations starting in 2026.
- On Tuesday, President Donald Trump announced Pfizer agreed to join TrumpRx, a new direct-to-consumer government platform launching in early 2026 with discounts of 50%–85%.
- Earlier this year the White House issued a May 12, 2025 Executive Order and July 31, 2025 letters to manufacturers urging price parity using most-favored-nation pricing, and said State Medicaid programs can access MFN prices for savings.
- Pfizer provided examples such as Duavee's $203 monthly price dropping to $30, a 85% discount, and Xeljanz's cost reducing from $6,000 to about $3,600 for direct purchases.
- Markets responded as Pfizer's share price rose 7% in the US on Tuesday and jumped 85% on the UK’s stock exchange after the announcement.
- Stacie Dusetzina cautioned that `The reality of who can actually benefit by paying cash for these drugs through this website, it's probably going to be a smaller number of people than what is being promoted,` and experts warn uninsured and insured patients may still face affordability issues.
15 Articles
15 Articles
Atlantic Magazine Praises Trump for Forcing Pfizer to Slash Drug Prices
It was grudging praise for President Donald Trump yet considering the source it was surprising bordering on astounding praise. Atlantic magazine writer Nicholas Florko should therefore be put on the alert to prepare for his shunning by his colleagues and other members of the media for daring to give what is in effect high praise to Trump for forcing Pfizer to agree to slash its drug prices with other pharmaceutical companies expected to follow s…
Let the Drug Pricing Games Begin!
Under pressure from the White House, Big Pharma has been touting “discounts” via Direct to Consumer (DTC) websites. Meanwhile, the Trump administration promises to unveil its own prescription website, immodestly named TrumpRx, in 2026. Prescription drug prices obviously are still too high, though President Biden’s Inflation Reduction Act (IRA) of 2022 was beginning to make headway in bringing them down. Unlike Biden’s IRA, these latest gestures …
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
